Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder

Clinica Chimica Acta

Volumn 331, Issue 1-2, 2003, Pages 69-77

  Bhuiyan, Jalaluddin ^a   Akhter, Javed ^a   O'Kane, Dennis J ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

BTA stat; Fibrin fibrinogen; Hemoglobin; NMP22; Telomerase

Indexed keywords

BLADDER TUMOR ASSOCIATED ANALYTE; HEMOGLOBIN; NUCLEAR MATRIX PROTEIN 22; TELOMERASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; BLADDER CARCINOMA; BLADDER IRRIGATION; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER TISSUE; CELL ASSAY; CHEMOLUMINESCENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ERYTHROCYTE; HEMOGLOBIN DIPSTICK; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINALYSIS; URINE CYTOLOGY;

EID: 0037402915     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00074-3     Document Type: Article

References (22)

1. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 50:2000;7-33.
2. Ruben H., Lutzeyer W., Fischer N., Deutz F., Lagrange W., Giani G. Natural history and treatment of low and high risk superficial bladder cancer. J. Urol. 139:1988;283-285.
3. Fair W.R., Fuks Z.Y., Scher H.I. Cancer of the bladder. 4th ed. DeVita V.T., Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology. vol. 1:1993;1056-1069 Lippincott Co. Philadelphia.
4. Konety B.R., Getzenberg R.H. Urine based markers of urological malignancy. J. Urol. 165:2001;600-611.
5. Cajulis R.S., Haines G.K., Frias-Hidvegi D., McVary K., Bacus J.W. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn. Cytopathol. 13:1995;214.
6. Sarosdy M.F., deVere White R.W., Soloway M.S., Sheinfield J., Hudson M.A., Schellhammer P.F.et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol. 154:1995;379.
7. Shay J.W., Wright W., Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta. 1072:1991;1-7.
8. Kyo S., Kunimi K., Uchibayashi T., Namiki M., Inoue M. Telomerase activity in human urothelial tumors. [see comments] Am. J. Clin. Pathol. 107:1997;555.
9. Lin Y., Miyamoto H., Fujinami K., Uemura H., Hosaka M., Iwasaki Y.et al. Telomerase activity in human bladder cancer. Clin. Cancer Res. 2:1996;929.
10. Kavaler E., Landman J., Chang Y., Droller M.J., Liu B. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer. 82:1998;708-714.
11. Muller M., Heine B., Heicappel R., Emrich T., Hummel M., Stein H.et al. Telomerase activity in bladder cancer, bladder washing and in urine. Int. J. Oncol. 9:1996;1169-1173.
12. Malkowicz S.B. The application of complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer. Urol. Clin. North Am. 2000;27-63.
13. Keesee S., Briggman J.B., Thill G., Wu Y.J. Utilization of nuclear matrix proteins for cancer diagnosis. Stein G. Critical review in eukaryotic gene expression. vol. 6:1996;189-214 Academic Press.
14. Berezney R., Coffey D.S. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun. 60:1972;1410.
15. Johnston B., Morales A., Emerson L., Lundie M. Rapid detection of bladder cancer: a comparative study of point of care tests. J. Urol. 158:1997;2098-2101.
16. Greene L.F., O'Shaughnessy E.J., Hendricks E.D. Study of 500 patients with asymptomatic microhematuria. J. Am. Med. Assoc. 161:1956;610.
17. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
18. Koss L.G. Tumors of the urinary tract and prostate in urinary sediment. 4th ed. Diagnostic cytology and its histopathologic bases. vol. 2:1992;951-963 Lippincott Co. Philadelphia. Chap. 23.
19. Yoshida K., Sugino T., Tahara H., Woodman A., Bolodeoku J., Nargund V.et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 79:1997;362-369.
20. Tatsu Y., Yoshikawa S. Homogeneous chemiluminescent immunoassay based on complement-mediated hemolysis of red blood cells. Anal. Chem. 62:1990;2103-2106.
21. Sarosdy M.F., Hudson M.A., Ellis W.J., Soloway M.S., deVere W.R., Sheinfeld J.et al. Improved detection of recurrent bladder cancer using the Bard BTA stat test. Urology. 50:1997;349.
22. Stampfer D.S., Carpinto G.A., Rodriguez-Villanueva J., Willsey L.W., Dinney C., Grossman H.B.et al. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J. Urol. 159:1998;394.